Table 1.
List of abbreviations.
| ABBREVIATIONS | |
|---|---|
| AE | Adverse events |
| Ce6 | Chlorin e6 |
| CLI | Cerenkov luminescence imaging |
| CLSM | Confocal laser scanning microscopy |
| CT | Chemotherapy |
| DOX | Doxorubicin |
| DPBF | 1,3-diphenyli-sobenzofuran |
| DVDMS | Sinoporphyrin sodium |
| EPR | Enhanced permeability and retention |
| ER | Endoplasmic reticulum |
| FDA | Federal Drug Administration |
| GBMs | Graphene based materials |
| GO | Graphene Oxide |
| GQDs | Graphene quantum dots |
| HA | Hyaluronic acid |
| HB | Hypocrellin B |
| hMPO | human myeloperoxidase |
| HPPH | 3-(1′-hexyloxyethyl)-3-devinyl pyropheophorbide-a |
| H2O2 | Hydrogen peroxide |
| ICG | Indocyanine green |
| IRT | Infrared thermal imaging |
| LSPR | Localized Surface plasmon resonance |
| MIRIBEL | Minimum Information Reporting in Bio–Nano Experimental Literature |
| miRNA | MicroRNA |
| MRI | Magnetic resonance imaging |
| NGO | Nanographene oxide |
| NIR | Near infrared |
| NMs | Nanomaterials |
| 1O2 | Singlet oxigen |
| PAI | Photoacoustic imaging |
| PDT | Photodynamic therapy |
| PEG | Polyethylene glycol |
| PEI | Polyethylenimine |
| PET | Positron emission tomography |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| PS | Photosensitizer |
| PTA | Photothermal conversion agents |
| PTT | Photothermal therapy |
| rGO | Reduced graphene oxide |
| RT | Radiotherapy |
| siRNA | Short interfering RNA |
| UCL imaging | Upconversion Luminescence Imaging |
| UCNPs | Upconversion nanoparticles |
| WHO | World health organization |
| ZnPc | Phthalocyanine |